Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Breaking through a plateau typically requires one or more adjustments
Tirzepatide is a synthetic peptide medication approved by the FDA with two major indications: Treatment of type 2 diabetes mellitus (T2DM) Management of obesity and overweight with weight-related health conditions Tirzepatide is unique because it acts as a dual agonist for two gut hormones: Glucose-dependent insulinotropic polypeptide (GIP) receptor Glucagon-like peptide-1 (GLP-1) receptor These hormones naturally regulate insulin release, reduce appetite, and slow gastric emptying after meals
Barrera declares no competing interests
Severe abdominal pain, persistent vomiting, dehydration, allergic reaction, or vision changes should be discussed urgently with a clinician
US$ 23.17
US$ 26.84
US$ 24.53
US$ 27.66
.jpg)
US$ 20.66
